Genetic & Functional Analyses of Hypertension Susceptibility Genes
遗传
基本信息
- 批准号:8506323
- 负责人:
- 金额:$ 56.97万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-08-01 至 2018-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAdultAffectAlanineAlternative SplicingBiochemistryBioinformaticsBiologicalBiologyBlood PressureCardiovascular DiseasesCaringClinicalCoronary heart diseaseDataDetectionDietDiseaseEssential HypertensionExcretory functionFatty acid glycerol estersFunctional RNAFundingGene ExpressionGene Expression ProfileGenesGeneticGenotypeGoalsGrantHeritabilityHumanHuman GenomeHypertensionHypotensionIndiumInternationalKidneyKidney DiseasesKnock-in MouseKnowledgeLeadLysineMessenger RNAMeta-AnalysisMiningMolecular BiologyMusMutationNephronsObesityPathogenesisPathway interactionsPatternPharmacogeneticsPhenotypePhosphotransferasesPhysiologyPlayPost-Transcriptional RegulationPredispositionPrevalenceProcessProlineProtein IsoformsProtein-Serine-Threonine KinasesProteinsPublic HealthPublishingRNA SequencesRNA SplicingRegulatory ElementRenal functionResearch PersonnelRisk FactorsRoleSignal TransductionSodiumSodium ChlorideStressStrokeSusceptibility GeneTechnologyTherapeutic InterventionThiazide DiureticsTissuesTranscriptTranscriptional RegulationVariantWorkabsorptionbaseblood pressure regulationdesigndriving forceeffective therapyfamilial hypertensionfollow-upgenetic variantgenome wide association studyin vitro Assayinsightinterestmembermouse modelnon-geneticnovelpreventpromoterpublic health relevanceresponsescreeningsymporterthiazidetranscriptome sequencing
项目摘要
DESCRIPTION (provided by applicant): Essential hypertension (HTN) affects more than 25% of adults worldwide, and is a significant risk factor for coronary heart disease, stroke, and renal
disease. Non-genetic factors such as obesity, high fat/sodium diet, stress, and physical inactivity
contribute to a steady increase in the prevalence of HTN despite remarkable improvement in HTN screening and treatment options. This phenomenon, termed Hypertension paradox, underscores the importance of understanding the genetic factors underlying HTN, so that personalized care can be developed to prevent and treat HTN. Variants that play a role in determining blood pressure (BP) and HTN susceptibility have been uncovered by recent genome-wide association studies (GWAS), but the biological underpinning of such signals is often unclear. This proposal aims to uncover the functional significance of such GWAS signals through a multi-disciplinary approach. Our prior GWAS effort demonstrated that variants in the serine-threonine kinase, STK39, are associated with BP and highlighted an incompletely understood network of kinases and co-transporters critical for normal salt excretion and BP control. Mouse models indicated that members of this network, such as with no lysine kinases (WNKs) and STK39-encoded Ste20-related proline-alanine-rich kinase (SPAK), might have unknown isoforms that are renal-segment specific and the distribution and interaction of these isoforms are crucial for proper renal function. Therefore we will generate cortex- and medulla-enriched human and mouse kidney transcriptomes by RNA sequencing, which is suitable for the detection of novel isoforms and rare transcripts. We will validate and characterize transcript and protein isoforms of these kinases and co-transporters to obtain a better understanding of how they work together to regulate renal sodium handling. Our objectives are to identify and characterize isoforms of this specific network of kinases and co-transporters that are functionally
distinct. In doing so, we will also provide high quality human and mouse nephron segment-specific transcriptomes for investigators interested in other aspects of renal gene expression. In a parallel but complementary aim, we will also examine novel GWAS signals yet to be characterized by combining our expertise in transcriptional regulation and bioinformatics to mine the ever-expanding annotation of regulatory elements in the human genome. Initially we will focus on replicated HTN and BP-associated variants, but our long-term objective is to build a bioinformatics pipeline designed to convert signals from large genetic studies, such as GWAS, to functional elements in the human genome so that the underlying biology of any phenotype or disease can be examined. To accomplish these goals, we have brought together investigators who are experts in hypertension genetics, transcriptional regulation, bioinformatics, molecular biology, biochemistry, and renal physiology.
描述(申请人提供):原发性高血压(HTN)影响全球超过25%的成年人,是冠心病、中风和肾脏疾病的重要危险因素。
疾病。非遗传因素,如肥胖、高脂肪/高钠饮食、压力和缺乏运动
尽管HTN筛查和治疗方案有了显著改善,但HTN患病率仍在稳步上升。这种现象被称为高血压悖论,强调了了解HTN背后的遗传因素的重要性,以便开发个性化护理来预防和治疗HTN。最近的全基因组关联研究发现了在决定血压(BP)和HTN易感性方面起作用的变异,但这些信号的生物学基础往往不清楚。这项建议旨在通过多学科的方法来揭示这种全球气候变化信号的功能意义。我们先前的Gwas工作表明,丝氨酸-苏氨酸激酶STK39的变体与BP相关,并突显了一个尚未完全了解的对正常盐排泄和BP控制至关重要的激酶和辅助转运蛋白网络。小鼠模型表明,这个网络的成员,如没有赖氨酸激酶(WNKS)和STK39编码的STK20相关的富含脯氨酸的丙氨酸激酶(SPAK),可能具有未知的肾节段特异性亚型,这些亚型的分布和相互作用对正常的肾脏功能至关重要。因此,我们将通过RNA测序产生皮质和髓质丰富的人和小鼠肾脏转录本,这适用于检测新的异构体和稀有转录本。我们将验证和表征这些激酶和共转运蛋白的转录和蛋白异构体,以更好地了解它们是如何共同调节肾脏钠处理的。我们的目标是识别和表征这一特定的激酶和共转运蛋白网络的亚型,它们在功能上是
截然不同。通过这样做,我们还将为对肾脏基因表达的其他方面感兴趣的研究人员提供高质量的人和小鼠肾单位片段特异性转录本。在一个平行但互补的目标中,我们还将通过结合我们在转录调控和生物信息学方面的专业知识来挖掘人类基因组中不断扩展的调控元件的注释,来研究尚未表征的新的GWAS信号。最初,我们将重点放在复制的HTN和BP相关变体上,但我们的长期目标是建立一条生物信息学管道,旨在将来自大型遗传研究的信号转换为人类基因组中的功能元件,以便可以检查任何表型或疾病的潜在生物学。为了实现这些目标,我们汇集了高血压遗传学、转录调控、生物信息学、分子生物学、生物化学和肾脏生理学方面的专家。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YEN PEI CHRISTY CHANG其他文献
YEN PEI CHRISTY CHANG的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YEN PEI CHRISTY CHANG', 18)}}的其他基金
Regulatory Role of CACNA1C Intronic DNA Variation Relevant to Psychiatric Disease
CACNA1C 内含子 DNA 变异与精神疾病相关的调节作用
- 批准号:
8684348 - 财政年份:2014
- 资助金额:
$ 56.97万 - 项目类别:
Regulatory Role of CACNA1C Intronic DNA Variation Relevant to Psychiatric Disease
CACNA1C 内含子 DNA 变异与精神疾病相关的调节作用
- 批准号:
8824578 - 财政年份:2014
- 资助金额:
$ 56.97万 - 项目类别:
The Relationship Between STK39, Salt Sensitivity, and HCTZ-induced BP Response
STK39、盐敏感性和 HCTZ 诱导的血压反应之间的关系
- 批准号:
7942840 - 财政年份:2009
- 资助金额:
$ 56.97万 - 项目类别:
The Relationship Between STK39, Salt Sensitivity, and HCTZ-induced BP Response
STK39、盐敏感性和 HCTZ 诱导的血压反应之间的关系
- 批准号:
7742809 - 财政年份:2009
- 资助金额:
$ 56.97万 - 项目类别:
Genetic & Functional Analyses of Hypertension Susceptibility Genes
遗传
- 批准号:
8827402 - 财政年份:2007
- 资助金额:
$ 56.97万 - 项目类别:
Genetic & Functional Analyses of Hypertension Susceptibility Genes
遗传
- 批准号:
9309009 - 财政年份:2007
- 资助金额:
$ 56.97万 - 项目类别:
Genetic & Functional Analyses of Chromosome 1 Hypertension Susceptibility Genes
遗传
- 批准号:
7645874 - 财政年份:2007
- 资助金额:
$ 56.97万 - 项目类别:
Genetic & Functional Analyses of Chromosome 1 Hypertension Susceptibility Genes
遗传
- 批准号:
7322180 - 财政年份:2007
- 资助金额:
$ 56.97万 - 项目类别:
Genetic & Functional Analyses of Chromosome 1 Hypertension Susceptibility Genes
遗传
- 批准号:
7477662 - 财政年份:2007
- 资助金额:
$ 56.97万 - 项目类别:
Genetic & Functional Analyses of Hypertension Susceptibility Genes
遗传
- 批准号:
8655175 - 财政年份:2007
- 资助金额:
$ 56.97万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 56.97万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 56.97万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 56.97万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 56.97万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 56.97万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 56.97万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 56.97万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 56.97万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 56.97万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 56.97万 - 项目类别:
Research Grant